tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ITRM Stock Latest News

Iterum Therapeutics Faces Nasdaq Delisting Notice
Company AnnouncementsIterum Therapeutics Faces Nasdaq Delisting Notice
22h ago
8K
ITRM
Iterum Therapeutics Launches New Antibiotic ORLYNVAH
PremiumCompany Announcements
Iterum Therapeutics Launches New Antibiotic ORLYNVAH
9d ago
8K
ITRM
Iterum Therapeutics announces U.S. commercial launch of ORLYNVAH
PremiumThe Fly
Iterum Therapeutics announces U.S. commercial launch of ORLYNVAH
9d ago
ITRM
Iterum Therapeutics’ Earnings Call: Optimism Amid Challenges
PremiumCompany Announcements
Iterum Therapeutics’ Earnings Call: Optimism Amid Challenges
23d ago
ITRM
Buy Rating for Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
PremiumRatings
Buy Rating for Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
23d ago
ITRM
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
PremiumCompany AnnouncementsIterum Therapeutics Prepares for ORLYNVAH™ Launch
24d ago
ITRM
Iterum Therapeutics reports Q2 non-GAAP EPS (13c) vs. (23c) last year
Premium
The Fly
Iterum Therapeutics reports Q2 non-GAAP EPS (13c) vs. (23c) last year
24d ago
ITRM
Iterum Therapeutics sees cash runway into 2026
Premium
The Fly
Iterum Therapeutics sees cash runway into 2026
24d ago
ITRM
Iterum Therapeutics Signs Manufacturing Agreement with ACS Dobfar
PremiumCompany Announcements
Iterum Therapeutics Signs Manufacturing Agreement with ACS Dobfar
25d ago
8K
ITRM
Iterum Therapeutics Sets AGM Date for September 2025
PremiumCompany Announcements
Iterum Therapeutics Sets AGM Date for September 2025
1M ago
8K
ITRM
Iterum Therapeutics appoints Coyne as CCO
PremiumThe Fly
Iterum Therapeutics appoints Coyne as CCO
2M ago
ITRM
Iterum Therapeutics announces publication of REASSURE trial in NEJM Evidence
PremiumThe Fly
Iterum Therapeutics announces publication of REASSURE trial in NEJM Evidence
2M ago
ITRM
Iterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
PremiumRatingsIterum Therapeutics: Strategic Positioning and Growth Potential with ORLYNVAH Launch
3M ago
ITRM
Iterum Therapeutics Partners with Eversana for US Launch
Premium
Company Announcements
Iterum Therapeutics Partners with Eversana for US Launch
3M ago
8K
ITRM
Iterum Therapeutics announces partnership for commercialization services
Premium
The Fly
Iterum Therapeutics announces partnership for commercialization services
3M ago
ITRM
Iterum Therapeutics Extends Milestone Payment Terms with Pfizer
PremiumCompany Announcements
Iterum Therapeutics Extends Milestone Payment Terms with Pfizer
3M ago
8K
ITRM
Iterum Therapeutics announces extension of term of promissory note
PremiumThe Fly
Iterum Therapeutics announces extension of term of promissory note
3M ago
PFE
ITRM
Iterum Therapeutics’ Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Iterum Therapeutics’ Earnings Call: Progress Amid Challenges
4M ago
ITRM
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
PremiumRatings
Buy Rating for Iterum Therapeutics: Strategic Positioning and Market Opportunities for Orlynvah
4M ago
ITRM
Iterum Therapeutics Prepares for ORLYNVAH™ Launch
PremiumCompany AnnouncementsIterum Therapeutics Prepares for ORLYNVAH™ Launch
4M ago
ITRM
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
Premium
Ratings
Iterum Therapeutics: Strategic Positioning and Financial Stability Justify Buy Rating
4M ago
ITRM
Iterum Therapeutics reports Q1 non-GAAP EPS (10c) vs. (38c) last year
Premium
The Fly
Iterum Therapeutics reports Q1 non-GAAP EPS (10c) vs. (38c) last year
4M ago
ITRM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >